MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Restless legs syndrome in a patient with hereditary hemochromatosis

Z. Fatima, S. Wijemanne (San Antonio, TX, USA)

Meeting: 2019 International Congress

Abstract Number: 2151

Keywords: Iron, Restless legs syndrome(RLS): Clinical features

Session Information

Date: Wednesday, September 25, 2019

Session Title: Phenomenology and Clinical Assessment of Movement Disorders

Session Time: 1:15pm-2:45pm

Location: Les Muses Terrace, Level 3

Objective: We present a case with two disorders, hereditary hemochromatosis (HH) and Restless Legs Syndrome (RLS), each related to the two ends of the spectrum of iron metabolism, to discuss the clinical presentation of each condition and management conundrums.

Background: HH is an autosomal recessive disorder of iron metabolism that causes excessive absorption of iron from the digestive tract leading to iron overload and end organ damage. Treatment involves repeated phlebotomies to remove the excess iron. RLS is characterized by leg paresthesia associated with an urge to move the legs after a period of rest or inactivity in the evening. The pathophysiology of RLS is not fully understood but is thought to be due to low iron concentration in the brain.

Method: We followed a 60-year-old male with HH homozygous for the C282Y HFE gene mutation complicated by end organ damage, who developed severe RLS associated with periodic limb movement disorder after repeated phlebotomy when his iron levels dropped to normal levels. There is no prior history of RLS or a family history of RLS.

Results: Our patient had a ferritin level of >9000 ng/mL prior to undergoing therapeutic phlebotomy. He developed severe RLS when his ferritin level dropped to 57 ng/mL. His RLS symptoms did not respond to dopamine agonists (pramipexole, rotigotine patch), gabapentin, codeine or its combinations. Although phlebotomies were discontinued, his ferritin level further dropped to 18 ng/mL due to gastrointestinal bleed which further aggravated the underlying RLS. At this point, due to the severity of his RLS, a decision was made to start a short course of oral iron therapy with close monitoring of his iron status. As his ferritin level increased, his RLS symptoms responded well to a combination of rotigotine patch and gabapentin.

Conclusion: HH and RLS can coexist in the same patient and close monitoring for RLS may be needed during therapeutic phlebotomy. RLS can be resistant to standard medical therapy and a short course of iron may be needed to help relieve symptoms. More studies would be needed to better understand the pathogenesis of RLS and its relationship to iron.

References: [1] Wijemanne S, Jankovic J. Restless legs syndrome: clinical presentation diagnosis and treatment. Sleep Med 2015;16(6):678-90. [2] Shaughnessy P, Lee J, O’Keeffe ST. Restless legs syndrome in patients with hereditary hemochromatosis. Neurology 2005;64(12):2158.

To cite this abstract in AMA style:

Z. Fatima, S. Wijemanne. Restless legs syndrome in a patient with hereditary hemochromatosis [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/restless-legs-syndrome-in-a-patient-with-hereditary-hemochromatosis/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/restless-legs-syndrome-in-a-patient-with-hereditary-hemochromatosis/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley